• Botulinum Toxin Type A Intralesional Monotherapy for Treating Human Hypertrophic Scar in a Dose-dependent Manner: in an Animal Model

    1 month ago - By Journal of Plastic, Reconstructive & Aesthetic Surgery

    We read with great interest the article entitled “Botulinum Toxin Type A Intralesional Monotherapy for Treating Human Hypertrophic Scar in a Dose-dependent Manner: in an Animal Model”1 by Li YW et al. in Journal of Plastic, Reconstructive & Aesthetic Surgery. In this article, the authors conducted an in vivo experiment on the effect of different doses of botulinum toxin Type A for treating human hypertrophic scar. They concluded that BTXA reduced the severity of hypertrophic scar in a dose-dependent manner by inhibiting proliferation and migration of scar fibroblasts.
    Read more ...

     

  • The headlines of Master Doctor